A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Evidence Lead?

Overview of attention for article published in Frontiers in oncology, June 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 16 X posts from 15 X users, with an upper bound of 16,679 followers.

RT @FuenteApolo: De dónde venimos, a dónde vamos #SBRT #radonc oligometastatic cancers https://t.co/yshP9WY3gg

RT @nuria_dios: Frontiers | A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Ev…

RT @nuria_dios: Frontiers | A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Ev…

RT @nuria_dios: Frontiers | A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Ev…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 12 additional X posts.